Consumer News Ftc Report Says Pharmacy Benefit Managers Keep Drug Prices High

Prescription drug middlemen fight FTC oversight at Eighth Circuit

The pharmacy benefit managers claim the government agency violates due process rights by acting as investigator, prosecutor and judge in its own administrative court. Read More

Eighth Circuit Hears Challenge to FTC Action Over Insulin Costs

Judges on a federal appeals court questioned pharmacy benefit managers Wednesday over the merits of their case against the Federal Trade Commission, which seeks to halt the agency’s internal ... Read More

Cigna Unit Sells Generic Drugs at Higher Prices, Report Says (1)

A little-known Cigna Group subsidiary that sells generic drugs charges prices that skew higher than many competing suppliers, according to a new analysis that raises questions about the company’s role ... Read More

Big Rebates Make High Drug Prices Look Like Savings. Here’s The Fix

NEW YORK, NEW YORK - JULY 23: Prescription drugs are displayed at NYC Discount Pharmacy in Manhattan on July 23, 2024, in New York City. In the U.S. drug market, higher list prices can paradoxically ... Read More

Let Drug Buyers See the Books of Pharmacy Benefit Managers

Pharmacy Benefit Managers (PBMs) play a large role in deciding which drugs patients receive and how much they pay. Yet their fees, rebates, and contracts remain largely hidden from employers, insurers ... Read More